(Reuters) – Europe’s drug regulator on Thursday recommended addition of a rare type of spinal inflammation as a side-effect of Johnson & Johnson’s COVID-19 vaccine. Read full story
(Reuters) – Europe’s drug regulator on Thursday recommended addition of a rare type of spinal inflammation as a side-effect of Johnson & Johnson’s COVID-19 vaccine. Read full story